Effects of beta-lactam antibiotics and L-arginine in the treatment of experimental sepsis in rats.
Machado
D P
DP
Nunes
F B
FB
Simões Pires
M G
MG
D'Avila
L C
LC
Leite
C E
CE
Ruschel
R E
RE
da Cunha
A A
AA
Saciura
V C
VC
Poloni
J A T
JA
Lunardelli
A
A
de Oliveira
J R
JR
Alves Filho
J C F
JC
Cunha
F Q
FQ
Dias
F S
FS
Poli de Figueiredo
C E
CE
D000818:Animals; D001120:Arginine / Q000627:therapeutic use*; D001202:Ascitic Fluid / Q000382:microbiology; D001398:Aztreonam / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016753:Interleukin-10 / Q000097:blood; D053583:Interleukin-1beta / Q000097:blood; D008297:Male; D009566:Nitrates / Q000097:blood; D009573:Nitrites / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D018805:Sepsis / Q000097:blood / Q000188:drug therapy*; D016019:Survival Analysis; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D047090:beta-Lactams / Q000627:therapeutic use*
D053583:Interleukin-1beta; D009566:Nitrates; D009573:Nitrites; D014409:Tumor Necrosis Factor-alpha; D047090:beta-Lactams; D016753:Interleukin-10; D002443:Ceftriaxone; D001120:Arginine; D001398:Aztreonam